FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to neurology, and deals with treatment of attention deficit disorder. For this purpose introduced is a pharmaceutical composition, containing potentiated form of antibodies to brain-specific protein S-100 and as an additional enhancing component - an activated-potentiated form of antibodies to endothelial NO-synthase.
EFFECT: method provides efficient treatment of attention deficit disorder due to synergic action of active components of the pharmaceutical composition.
9 cl, 4 tbl, 1 dwg, 2 ex
